Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Data Reporting and Recording01:24

Data Reporting and Recording

5.5K
Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.5K
How Data are Classified: Categorical Data01:11

How Data are Classified: Categorical Data

45.2K
A variable, usually notated by capital letters such as X and Y, is a characteristic or measurement that can be determined for each member of a population. Data are the actual values of variables. They may be numbers, or they may be words. Datum is a single value.
Data are classified based on whether they are measurable or not. Categorical data cannot be measured; instead, it can be divided into categories. For example, if Y denotes a person's party affiliation, some examples of Y include...
45.2K
How Data are Classified: Numerical Data00:59

How Data are Classified: Numerical Data

38.4K
Data that are countable or measurable in specific units are called numerical or quantitative data. Quantitative data are always numbers. Quantitative data are the result of counting or measuring the attributes of a population. Amount of money, pulse rate, weight, number of people living in a town, and number of students who opt for statistics are examples of quantitative data.
Quantitative data may be either discrete or continuous. All quantitative data that take on only specific numerical...
38.4K
Data Validation01:15

Data Validation

2.3K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
2.3K
Data Validation01:03

Data Validation

7.0K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
7.0K
Data Collection II01:29

Data Collection II

10.2K
The nursing history captures and records the patient's health status, so that a care plan evolves to meet the patient's individual needs. The nursing health history is a part of the initial assessment. A comprehensive history covers all health dimensions and plays a significant role in the assessment process. A comprehensive history includes the patient's biographical information, reasons for seeking health care, expectations, present and past health history, medications, and...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of surrogate endpoints for survival outcomes using the surrogate package in R.

Computer methods and programs in biomedicine·2026
Same author

Integrating oral health screening into general practice: validation study of the Oral Health Screener.

Scientific reports·2026
Same author

Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive Diseases.

Statistics in medicine·2026
Same author

Does Everyone Need CEA? A Case for Selective Omission After Colorectal Cancer Resection.

ANZ journal of surgery·2026
Same author

Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease.

Nature medicine·2026
Same author

Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA).

Neurology and therapy·2026

Related Experiment Video

Updated: Feb 14, 2026

Gathering Self-Initiated Rat Behavioral Data to Characterize Post-Stroke Deficits
05:08

Gathering Self-Initiated Rat Behavioral Data to Characterize Post-Stroke Deficits

Published on: March 15, 2024

1.6K

Handling Missing Data in Participants with Baseline but No Post-Baseline Data.

Craig Mallinckrodt1, Ilya Lipkovich2, Samuel Dickson1

  • 1Pentara Corporation, Millcreek, Utah, USA.

Pharmaceutical Statistics
|February 13, 2026
PubMed
Summary
This summary is machine-generated.

Handling participants with no post-baseline data in clinical trials is crucial. A strategy using baseline as a covariate, with change set to zero, effectively controlled errors and maintained power for treatment effect estimation.

Keywords:
clinical trialsestimandsintention‐to‐treatmissing data

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

12.8K

Related Experiment Videos

Last Updated: Feb 14, 2026

Gathering Self-Initiated Rat Behavioral Data to Characterize Post-Stroke Deficits
05:08

Gathering Self-Initiated Rat Behavioral Data to Characterize Post-Stroke Deficits

Published on: March 15, 2024

1.6K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.8K
Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

12.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Data Analysis

Background:

  • Participants randomized to treatment but lacking post-baseline data present a significant challenge in clinical trials.
  • Maintaining randomization integrity necessitates including these participants in analyses.
  • Estimating hypothetical outcomes for discontinued participants is essential due to missing data on events and results.

Purpose of the Study:

  • To evaluate various analytical strategies for handling participants with no post-baseline data in clinical trials.
  • To identify methods that preserve randomization while providing unbiased treatment effect estimates.
  • To compare the performance of imputation-based and likelihood-based analyses in simulated and real-world data.

Main Methods:

  • Comparison of different statistical models, including those using baseline as a covariate, constraining baseline values, and unconstrained analyses.
  • Simulation studies and analysis of real clinical trial data were employed.
  • Specific focus on a strategy assigning a change of zero to the first post-baseline visit and using baseline as a covariate.

Main Results:

  • Models incorporating baseline as a covariate or constraining baseline values showed similar, superior results compared to unconstrained models.
  • The strategy of setting change to zero and using baseline as a covariate effectively controlled Type I error and demonstrated strong power.
  • Treatment contrasts remained unbiased when missingness was random or treatment-related, but outcome-related missingness introduced within-group bias, though it balanced out across arms.

Conclusions:

  • No single analytical approach is universally optimal for managing participants with no post-baseline data in clinical trials.
  • The choice of method should be tailored to the specific characteristics of the clinical trial and the nature of missing data.
  • The proposed strategy using baseline as a covariate offers a robust approach for handling such participants, balancing statistical power and error control.